Excluyendo al estudio ELIXA (en el cual se incluyeron pacientes con eventos coronarios recientes), los resultados mostraron una reduccin del 22% del desenlace compuesto renal (HR: 0.78
If you experience any side effects or concerns, contact your healthcare provider promptly
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
FDA's investigation is ongoing, and the agency is working to protect the U.S
Cyanocobalamin injection may be prescribed to treat or prevent B12 deficiency related to pernicious anemia, absorption problems, certain medications, or strict vegan diets